disturbance of the normal bacterial flora primarily composed of anaerobes and (5) in-hospital infections due to anaerobes. We believe that this guideline is extremely important on an international scale, because it fully describes diagnosis and treatment of anaerobic infections as applicable to each medical specialty and disease category. Although there may be readers who do not fully agree with the publication of this guideline, we believe that guidelines will continue to be developed and improved over time. We hope that the validity of this guideline will be verified by readers and users, with the goal of making it more complete through the efforts of the many people involved.
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